DNLI logo

Denali Therapeutics Inc. (DNLI) Cash From Investing

Annual CFI:

-$88.76M-$338.06M(-135.60%)
December 31, 2024

Summary

  • As of today, DNLI annual cash from investing is -$88.76 million, with the most recent change of -$338.06 million (-135.60%) on December 31, 2024.
  • During the last 3 years, DNLI annual cash from investing has fallen by -$67.13 million (-310.41%).
  • DNLI annual cash from investing is now -135.60% below its all-time high of $249.31 million, reached on December 31, 2023.

Performance

DNLI Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIcash flow metrics

Quarterly CFI:

$157.94M+$139.19M(+742.41%)
June 30, 2025

Summary

  • As of today, DNLI quarterly cash from investing is $157.94 million, with the most recent change of +$139.19 million (+742.41%) on June 30, 2025.
  • Over the past year, DNLI quarterly cash from investing has increased by +$59.37 million (+60.23%).
  • DNLI quarterly cash from investing is now -8.29% below its all-time high of $172.21 million, reached on December 31, 2024.

Performance

DNLI Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIcash flow metrics

TTM CFI:

$442.55M+$59.37M(+15.49%)
June 30, 2025

Summary

  • As of today, DNLI TTM cash from investing is $442.55 million, with the most recent change of +$59.37 million (+15.49%) on June 30, 2025.
  • Over the past year, DNLI TTM cash from investing has increased by +$623.21 million (+344.96%).
  • DNLI TTM cash from investing is now at all-time high.

Performance

DNLI TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNLIcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

DNLI Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-135.6%+60.2%+345.0%
3Y3 Years-310.4%+78.2%+459.8%
5Y5 Years-160.1%+619.3%+307.3%

DNLI Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-135.6%+37.2%-8.3%+134.8%at high+335.5%
5Y5-Year-135.6%+85.8%-8.3%+134.8%at high+169.7%
All-TimeAll-Time-135.6%+85.8%-8.3%+134.8%at high+169.7%

DNLI Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$157.94M(+742.4%)
$442.55M(+15.5%)
Mar 2025
-
$18.75M(-89.1%)
$383.18M(+531.7%)
Dec 2024
-$88.76M(-135.6%)
$172.21M(+83.9%)
-$88.76M(+52.8%)
Sep 2024
-
$93.66M(-5.0%)
-$187.92M(-4.0%)
Jun 2024
-
$98.57M(+121.8%)
-$180.66M(-62.5%)
Mar 2024
-
-$453.19M(-720.4%)
-$111.16M(-144.6%)
Dec 2023
$249.31M(+276.3%)
$73.05M(-27.6%)
$249.31M(+411.9%)
Sep 2023
-
$100.91M(-40.0%)
$48.70M(+232.4%)
Jun 2023
-
$168.07M(+281.3%)
-$36.79M(+68.3%)
Mar 2023
-
-$92.72M(+27.3%)
-$116.22M(+17.8%)
Dec 2022
-$141.39M(-553.8%)
-$127.56M(-927.3%)
-$141.39M(-159.1%)
Sep 2022
-
$15.42M(-82.6%)
-$54.58M(+55.6%)
Jun 2022
-
$88.63M(+175.2%)
-$123.00M(-7.8%)
Mar 2022
-
-$117.88M(-189.3%)
-$114.10M(-427.6%)
Dec 2021
-$21.63M
-$40.75M(+23.1%)
-$21.63M(+93.8%)
Sep 2021
-
-$53.01M(-154.3%)
-$348.22M(+31.4%)
DateAnnualQuarterlyTTM
Jun 2021
-
$97.54M(+483.9%)
-$507.33M(+20.1%)
Mar 2021
-
-$25.41M(+93.1%)
-$635.28M(-1.9%)
Dec 2020
-$623.21M(-521.9%)
-$367.34M(-73.2%)
-$623.21M(-191.9%)
Sep 2020
-
-$212.12M(-597.5%)
-$213.48M(-543.5%)
Jun 2020
-
-$30.41M(-128.1%)
$48.13M(-66.2%)
Mar 2020
-
-$13.33M(-131.5%)
$142.43M(-3.6%)
Dec 2019
$147.71M(+151.4%)
$42.38M(-14.4%)
$147.71M(+236.3%)
Sep 2019
-
$49.49M(-22.5%)
$43.92M(+12.2%)
Jun 2019
-
$63.88M(+893.8%)
$39.16M(+574.6%)
Mar 2019
-
-$8.05M(+86.9%)
$5.80M(+102.0%)
Dec 2018
-$287.42M(-598.2%)
-$61.40M(-237.3%)
-$287.42M(+10.5%)
Sep 2018
-
$44.73M(+46.5%)
-$321.17M(+12.2%)
Jun 2018
-
$30.53M(+110.1%)
-$365.89M(+7.7%)
Mar 2018
-
-$301.27M(-216.6%)
-$396.42M(-316.6%)
Dec 2017
-$41.17M(+81.2%)
-$95.15M(-402.2%)
-$95.15M(-402.2%)
Dec 2016
-$219.00M(-7052.3%)
-$18.95M
-$18.95M
Dec 2015
-$3.06M
-
-

FAQ

  • What is Denali Therapeutics Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Denali Therapeutics Inc.?
  • What is Denali Therapeutics Inc. annual cash from investing year-on-year change?
  • What is Denali Therapeutics Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Denali Therapeutics Inc.?
  • What is Denali Therapeutics Inc. quarterly cash from investing year-on-year change?
  • What is Denali Therapeutics Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Denali Therapeutics Inc.?
  • What is Denali Therapeutics Inc. TTM cash from investing year-on-year change?

What is Denali Therapeutics Inc. annual cash from investing?

The current annual cash from investing of DNLI is -$88.76M

What is the all-time high annual cash from investing for Denali Therapeutics Inc.?

Denali Therapeutics Inc. all-time high annual cash from investing is $249.31M

What is Denali Therapeutics Inc. annual cash from investing year-on-year change?

Over the past year, DNLI annual cash from investing has changed by -$338.06M (-135.60%)

What is Denali Therapeutics Inc. quarterly cash from investing?

The current quarterly cash from investing of DNLI is $157.94M

What is the all-time high quarterly cash from investing for Denali Therapeutics Inc.?

Denali Therapeutics Inc. all-time high quarterly cash from investing is $172.21M

What is Denali Therapeutics Inc. quarterly cash from investing year-on-year change?

Over the past year, DNLI quarterly cash from investing has changed by +$59.37M (+60.23%)

What is Denali Therapeutics Inc. TTM cash from investing?

The current TTM cash from investing of DNLI is $442.55M

What is the all-time high TTM cash from investing for Denali Therapeutics Inc.?

Denali Therapeutics Inc. all-time high TTM cash from investing is $442.55M

What is Denali Therapeutics Inc. TTM cash from investing year-on-year change?

Over the past year, DNLI TTM cash from investing has changed by +$623.21M (+344.96%)
On this page